Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score’s impact

Tatsuo Fukushima(Osaka University of Pharmaceutical Sciences), Haruhito Azuma(Osaka University of Pharmaceutical Sciences), Yosuke Hirasawa(Cedars-Sinai Medical Center), Takuya Tsujino(Osaka University of Pharmaceutical Sciences), Tomoaki Takai(Osaka University of Pharmaceutical Sciences), Atsuhiko Yoshizawa(Fujita Health University Hospital), Fumihiko Urabe(Jikei University School of Medicine), Tatsushi Kawada(Okayama University), Ryoichi Maenosono(Osaka University of Pharmaceutical Sciences), Wataru Fukuokaya(Jikei University School of Medicine), Keita Nakamori(Osaka University of Pharmaceutical Sciences), Satoshi Katayama(Okayama University), Kazuki Nishimura(Osaka University of Pharmaceutical Sciences), Kyosuke Nishio(Osaka University of Pharmaceutical Sciences), Takafumi Yanagisawa(Jikei University School of Medicine), Takahiro Adachi(Tokyo Medical University), Ko Nakamura, Shingo Toyoda(Kindai University), Masanobu Saruta(Fujita Health University), Yoshio Ohno(Tokyo Medical University), Teruo Inamoto(Hamamatsu University), Motoo Araki(Okayama University), Takeshi Hashimoto(Tokyo Medical University), Kazumasa Komura(Kawasaki Medical School), Kazutoshi Fujita(Kindai University), Ryoichi Shiroki(Fujita Health University), Takahiro Kimura(Jikei University School of Medicine), Moritoshi Sakamoto(Osaka University of Pharmaceutical Sciences), Kengo Iwatsuki(Osaka University of Pharmaceutical Sciences), Taizo Uchimoto(Osaka University of Pharmaceutical Sciences), Tomohisa Matsunaga(Osaka University of Pharmaceutical Sciences), Keiichiro Mori(Jikei University School of Medicine), Kiyoshi Takahara(Osaka Medical and Pharmaceutical University)
World Journal of Urology
February 24, 2025
Cited by 1


Related Papers